We are live on ! Find out more
Positive
Neutral
Negative
Sentiment 3-Months
Positive 42.1%
Neutral 52.6%
Negative 5.3%

Neutral
GlobeNewsWire
26 days ago
ADT Earns Two 2026 Buyer's Choice Awards from ConsumerAffairs, Based on Customer Reviews
BOCA RATON, Fla., June 18, 2026 (GLOBE NEWSWIRE) -- ADT Inc. (NYSE: ADT), the leader in smart home security solutions, has earned two 2026 Buyer's Choice Awards from ConsumerAffairs, a leading platform for verified consumer reviews.
ADT Earns Two 2026 Buyer's Choice Awards from ConsumerAffairs, Based on Customer Reviews
Neutral
GlobeNewsWire
27 days ago
ADT Joins Board of Directors of the Connectivity Standards Alliance, Reinforcing Its Role in Shaping the Future of the Connected Home
BOCA RATON, Fla., June 17, 2026 (GLOBE NEWSWIRE) -- ADT Inc. (NYSE: ADT), the leader in smart home security solutions, today announced it has joined the Board of Directors of the Connectivity Standards Alliance (CSA), the global organization behind Matter, Zigbee and Aliro, foundational standards shaping the future of connected living.
ADT Joins Board of Directors of the Connectivity Standards Alliance, Reinforcing Its Role in Shaping the Future of the Connected Home
Positive
Zacks Investment Research
27 days ago
Should Value Investors Buy ADT (ADT) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy ADT (ADT) Stock?
Positive
Seeking Alpha
1 month ago
Buy 2 Ideal June DiviDogs Per Barron's April To June Picks
Barron's April–June 2026 stock picks highlight 32 names, with a focus on 19 high-yield, dividend-paying equities subjected to contrarian 'dogcatcher' analysis. Top ten dividend stocks yield 1.33%–5.16%, with Build-A-Bear (BBW) and Kingstone (KINS) showing standout projected returns of 82.16% and 239.6%, respectively. CBL & Associates (CBL) and ADT Inc. (ADT) are identified as 'safer' ideal dividend dogs, with dividends from $1K invested exceeding their share prices.
Buy 2 Ideal June DiviDogs Per Barron's April To June Picks
Positive
Zacks Investment Research
1 month ago
Are Investors Undervaluing ADT (ADT) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Investors Undervaluing ADT (ADT) Right Now?
Positive
Zacks Investment Research
1 month ago
ADT (ADT) Upgraded to Buy: Here's Why
ADT (ADT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ADT (ADT) Upgraded to Buy: Here's Why
Negative
CNET
1 month ago
ADT Announces Yet Another DIY Home Security Line, Now With AI Features
ADT Blu shouldn't be confused with Blue by ADT, or ADT Self Setup. I know, it's a mess.
ADT Announces Yet Another DIY Home Security Line, Now With AI Features
Positive
Seeking Alpha
1 month ago
ADT Has A Clear AI-Driven Future (Rating Upgrade)
ADT becomes a more attractive investment following Apollo's complete exit and significant share repurchases. Despite flat revenue and EPS guidance in 2026, ADT targets a 5% revenue and 10% EPS CAGR, leveraging AI and the Origin AI acquisition for operational improvements and differentiation. My updated DCF values ADT at $10.33 per share, indicating a 50% undervaluation with an 8.5% shareholder yield.
ADT Has A Clear AI-Driven Future (Rating Upgrade)
Neutral
Business Wire
2 months ago
AUA 2026: Phase II ARASEC Data Further Supports the Efficacy and Safety of NUBEQA® (darolutamide) Plus ADT in Patients with Metastatic Castration-Sensitive Prostate Cancer
WHIPPANY, N.J.--(BUSINESS WIRE)--AUA 2026: Phase II ARASEC Data Further Supports the Efficacy and Safety of NUBEQA® (darolutamide) Plus ADT in Patients with mCSPC.
AUA 2026: Phase II ARASEC Data Further Supports the Efficacy and Safety of NUBEQA® (darolutamide) Plus ADT in Patients with Metastatic Castration-Sensitive Prostate Cancer
Positive
Zacks Investment Research
2 months ago
Is ADT (ADT) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is ADT (ADT) Stock Undervalued Right Now?